These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of Ox-LDL/LOX-1/NF-κB signaling pathway in regulation of atherosclerotic plaque growth by testosterone in male rabbits. Li S, Guo Y, Zhu P, Yang T. Vascul Pharmacol; 2013; 59(5-6):131-7. PubMed ID: 23022624 [Abstract] [Full Text] [Related]
12. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice. Bai X, Wang S, Shu L, Cao Q, Hu H, Zhu Y, Chen C. J Ethnopharmacol; 2024 Jun 12; 327():118006. PubMed ID: 38442806 [Abstract] [Full Text] [Related]
13. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis. Mehta JL. Can J Cardiol; 2004 Aug 12; 20 Suppl B():32B-36B. PubMed ID: 15309203 [Abstract] [Full Text] [Related]
14. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage. Matsuda N, Ohkuma H, Naraoka M, Munakata A, Shimamura N, Asano K. J Neurosurg; 2014 Sep 12; 121(3):621-30. PubMed ID: 24949677 [Abstract] [Full Text] [Related]
17. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1. Takemura Y, Okamoto M, Hasegawa M, Hatanaka K, Kubota S. Biosci Biotechnol Biochem; 2019 Jun 12; 83(6):1094-1101. PubMed ID: 30871430 [Abstract] [Full Text] [Related]